Cite
MLA Citation
R. R. Henry et al.. “Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials.” Diabetes, obesity & metabolism, vol. 17, no. 6, n.d., pp. 560–565. http://access.bl.uk/ark:/81055/vdc_100025876685.0x00002a